Hebei Jianxin Chemical Co., Ltd. (SHE:300107)
China · Delayed Price · Currency is CNY 9.45
-0.20 (-2.07%)
Feb 27, 2026, 3:04 PM CST
Hebei Jianxin Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 499.96 | 604.79 | 657.85 | 740.7 | 622.62 | 561.99 |
Other Revenue | 0.58 | 0.58 | 0.36 | 1.77 | 5.53 | 1.72 |
| 500.54 | 605.38 | 658.21 | 742.47 | 628.15 | 563.71 | |
Revenue Growth (YoY) | -21.59% | -8.03% | -11.35% | 18.20% | 11.43% | -39.07% |
Cost of Revenue | 465.81 | 549.85 | 580.04 | 625.27 | 554.21 | 448.77 |
Gross Profit | 34.74 | 55.53 | 78.17 | 117.2 | 73.94 | 114.94 |
Selling, General & Admin | 15.95 | 25.18 | 42.68 | 39.86 | 50.34 | 54.41 |
Research & Development | 26.74 | 35.67 | 35.15 | 31.81 | 28.27 | 24.82 |
Other Operating Expenses | 4.7 | 3.95 | 5.78 | 5.06 | 4.28 | 4.96 |
Operating Expenses | 47.92 | 64.48 | 83.42 | 78.19 | 82.07 | 82.78 |
Operating Income | -13.18 | -8.96 | -5.25 | 39 | -8.13 | 32.16 |
Interest Expense | -0.01 | -0.02 | -0.22 | -0.76 | -0.55 | -0.49 |
Interest & Investment Income | 10.4 | 13.86 | 14.75 | 16.09 | 18.53 | 27.94 |
Currency Exchange Gain (Loss) | 3.75 | 3.75 | 2.02 | 7.64 | -1.72 | -3.74 |
Other Non Operating Income (Expenses) | -1.68 | -0.3 | -0.24 | -0.22 | -0.24 | -0.3 |
EBT Excluding Unusual Items | -0.72 | 8.33 | 11.06 | 61.75 | 7.88 | 55.57 |
Asset Writedown | 2.76 | -0.24 | -0.57 | -0.34 | -0.16 | -8.79 |
Other Unusual Items | 3.44 | 3.44 | 2.95 | 2.81 | 4.29 | 3.4 |
Pretax Income | 5.48 | 11.54 | 13.43 | 64.22 | 12.01 | 50.18 |
Income Tax Expense | -6.16 | -7.83 | -1.3 | 2.95 | -1.63 | 4.84 |
Earnings From Continuing Operations | 11.65 | 19.37 | 14.73 | 61.27 | 13.64 | 45.34 |
Minority Interest in Earnings | - | - | - | - | - | 0.07 |
Net Income | 11.65 | 19.37 | 14.73 | 61.27 | 13.64 | 45.41 |
Net Income to Common | 11.65 | 19.37 | 14.73 | 61.27 | 13.64 | 45.41 |
Net Income Growth | -34.43% | 31.44% | -75.96% | 349.12% | -69.95% | -86.05% |
Shares Outstanding (Basic) | 565 | 560 | 552 | 552 | 552 | 550 |
Shares Outstanding (Diluted) | 568 | 573 | 573 | 557 | 552 | 550 |
Shares Change (YoY) | -1.39% | -0.06% | 2.91% | 0.85% | 0.36% | -0.82% |
EPS (Basic) | 0.02 | 0.03 | 0.03 | 0.11 | 0.02 | 0.08 |
EPS (Diluted) | 0.02 | 0.03 | 0.03 | 0.11 | 0.02 | 0.08 |
EPS Growth | -33.51% | 31.52% | -76.64% | 345.34% | -70.06% | -85.94% |
Free Cash Flow | -47.78 | -85.92 | -2.86 | 56.07 | -59.5 | 175.89 |
Free Cash Flow Per Share | -0.08 | -0.15 | -0.01 | 0.10 | -0.11 | 0.32 |
Dividend Per Share | 0.016 | 0.016 | 0.016 | 0.060 | 0.100 | 0.100 |
Dividend Growth | - | - | -73.33% | -40.00% | - | -83.33% |
Gross Margin | 6.94% | 9.17% | 11.88% | 15.78% | 11.77% | 20.39% |
Operating Margin | -2.63% | -1.48% | -0.80% | 5.25% | -1.29% | 5.71% |
Profit Margin | 2.33% | 3.20% | 2.24% | 8.25% | 2.17% | 8.05% |
Free Cash Flow Margin | -9.54% | -14.19% | -0.43% | 7.55% | -9.47% | 31.20% |
EBITDA | 59.58 | 60.24 | 59.2 | 104.66 | 59.28 | 94.95 |
EBITDA Margin | 11.90% | 9.95% | 9.00% | 14.10% | 9.44% | 16.84% |
D&A For EBITDA | 72.75 | 69.2 | 64.46 | 65.65 | 67.41 | 62.79 |
EBIT | -13.18 | -8.96 | -5.25 | 39 | -8.13 | 32.16 |
EBIT Margin | -2.63% | -1.48% | -0.80% | 5.25% | -1.29% | 5.71% |
Effective Tax Rate | - | - | - | 4.59% | - | 9.65% |
Revenue as Reported | 500.54 | 605.38 | 658.21 | 742.47 | 628.15 | 563.71 |
Advertising Expenses | - | - | - | - | 0.03 | 0.02 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.